Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial (Q44350321)

From Wikidata

Jump to navigation Jump to search

scientific article published on 8 November 2011

Language	Label	Description	Also known as
English	Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial	scientific article published on 8 November 2011

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Cross-protective efficacy of HPV-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by non-vaccine oncogenic HPV types: 4-year end-of-study analysis of the randomised, double-blind PATRICIA trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1 reference

based on heuristic

inferred from title

Xavier Castellsagué

2

object named as

Xavier Castellsagué

0 references

object named as

Frank Struyf

25

0 references

object named as

Dan Apter

9

0 references

Jorge Salmerón

object named as

Jorge Salmerón

7

0 references

4

object named as

Anne Szarewski

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Cosette M Wheeler

1

object named as

Cosette M Wheeler

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

5

object named as

Jorma Paavonen

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Francesc Xavier Bosch José

19

object named as

F Xavier Bosch

2 references

ORCID Public Data File 2021

Europe PubMed Central

PubMed publication ID

2 December 2017

S. Rachel Skinner

12

object named as

S Rachel Skinner

2 references

ORCID Public Data File 2021

Europe PubMed Central

PubMed publication ID

2 December 2017

Suzanne Marie Garland

3

object named as

Suzanne M Garland

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

6

object named as

Paulo Naud

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

8

object named as

Song-Nan Chow

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Henry C Kitchener

10

object named as

Henry Kitchener

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Unnop Jaisamrarn

13

object named as

Unnop Jaisamrarn

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

14

object named as

Genara Limson

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Barbara Romanowski

15

object named as

Barbara Romanowski

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

16

object named as

Fred Y Aoki

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Willy A J Poppe

18

object named as

Willy A J Poppe

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

23

object named as

Toufik Zahaf

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Dominique Descamps

24

object named as

Dominique Descamps

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

HPV PATRICIA Study Group

28

object named as

HPV PATRICIA Study Group

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

author name string

Júlio C Teixeira

11

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Tino F Schwarz

17

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Diane M Harper

20

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Warner Huh

21

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Karin Hardt

22

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Gary Dubin

26

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Matti Lehtinen

27

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

publication date

8 November 2011

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Lancet Oncology Commission

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

13

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

100-110

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiologic classification of human papillomavirus types associated with cervical cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Classification of weakly carcinogenic human papillomavirus types: addressing the limits of epidemiology at the borderline

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus type distribution in 30,848 invasive cervical cancers worldwide: Variation by geographical region, histological type and year of publication

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Crystal structures of four types of human papillomavirus L1 capsid proteins: understanding the specificity of neutralizing monoclonal antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Deletion of a major neutralizing epitope of human papillomavirus type 16 virus-like particles

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Evolutionary dynamics of variant genomes of human papillomavirus types 18, 45, and 97.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Antibodies from women immunized with Gardasil cross-neutralize HPV 45 pseudovirions

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of a prophylactic adjuvanted bivalent L1 virus-like-particle vaccine against infection with human papillomavirus types 16 and 18 in young women: an interim analysis of a phase III double-blind, randomised controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine against cervical infection and precancer caused by oncogenic HPV types (PATRICIA): final analysis of a double-blind, randomised study in young women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Impact of human papillomavirus (HPV)-6/11/16/18 vaccine on all HPV-associated genital diseases in young women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistence of type-specific human papillomavirus infection among cytologically normal women

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent Genital Human Papillomavirus Infection as a Risk Factor for Persistent Cervical Dysplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Persistent human papillomavirus infection and cervical neoplasia: a systematic review and meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Long-term absolute risk of cervical intraepithelial neoplasia grade 3 or worse following human papillomavirus infection: role of persistence

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Enrolment of 22,000 adolescent women to cancer registry follow-up for long-term human papillomavirus vaccine efficacy: guarding against guessing

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Highly effective detection of human papillomavirus 16 and 18 DNA by a testing algorithm combining broad-spectrum and type-specific PCR.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

A review of human carcinogens--Part B: biological agents

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of HPV type distribution in high-grade cervical lesions and cervical cancer: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The carcinogenicity of human papillomavirus types reflects viral evolution.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Human papillomavirus genotype distributions: implications for vaccination and cancer screening in the United States

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Type-dependent integration frequency of human papillomavirus genomes in cervical lesions.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in sexually active women aged 16-26 years

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of quadrivalent human papillomavirus (HPV; types 6, 11, 16, and 18) L1 virus-like particle vaccine on infection and disease due to oncogenic nonvaccine HPV types in generally HPV-naive women aged 16-26 years

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Prevalence of types 16 and 33 is increased in high-risk human papillomavirus positive women with cervical intraepithelial neoplasia grade 2 or worse

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Incident cervical HPV infections in young women: transition probabilities for CIN and infection clearance

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

The rising incidence of adenocarcinoma relative to squamous cell carcinoma of the uterine cervix in the United States--a 24-year population-based study

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Epidemiology and natural history of human papillomavirus infections and type-specific implications in cervical neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple human papillomavirus genotype infections in cervical cancer progression in the study to understand cervical cancer early endpoints and determinants

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Distribution of HPV genotypes in 282 women with cervical lesions: evidence for three categories of intraepithelial lesions based on morphology and HPV type.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Rationale and design of a community-based double-blind randomized clinical trial of an HPV 16 and 18 vaccine in Guanacaste, Costa Rica

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

HPV16/18 L1 VLP vaccine induces cross-neutralizing antibodies that may mediate cross-protection

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunological analyses of human papillomavirus capsids

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of two cross-neutralizing linear epitopes within the L1 major capsid protein of human papillomaviruses

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Characterization of neutralizing epitopes within the major capsid protein of human papillomavirus type 33.

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of neutralizing conformational epitopes on the human papillomavirus type 31 major capsid protein and functional implications

1 reference

https://api.crossref.org/works/10.1016%2FS1470-2045%2811%2970287-X

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S1470-2045(11)70287-X

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

release_rlv3ogr4ezfinjhdtam3aoo3hq

1 reference

https://api.fatcat.wiki/v0/release/rlv3ogr4ezfinjhdtam3aoo3hq

24 November 2022

based on heuristic

mapped directly with Wikidata item

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

2 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44350321&oldid=2109643494"